This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
C3_RENAL_CELL_CARCINOMA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1265 |
4. Check minimum number of eventsNone |
1265 |
5. Include endpointsNone |
1265 |
6. Filter based on genotype QC (FinnGen only) |
1265 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Renal cell carcinoma of kidney
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1265 | 474 | 791 |
| Unadjusted period prevalence (%) | 0.28 | 0.16 | 0.35 |
| Median age at first event (years) | 63.23 | 60.73 | 64.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1176
- Matched controls
- 11771
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
323.0
413
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1012
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
323.0
1021
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
323.0
334
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
227.2
323.0
574
49
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
310
*
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
161.2
151
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
339.8
149.3
148
5
7125
FHL
Nephrectomy (extrrafascial)
+∞
147.0
138
*
197
Kela drug reimbursment
Sunitinib
+∞
122.0
115
*
JN4AD
NOMESCO Finland
Body CT examination
13.4
115.9
212
190
KAC00
NOMESCO Finland
Nephrectomy
603.1
112.9
110
*
JN4BD
NOMESCO Finland
Extensive body CT
10.1
111.3
237
287
L01XE04
ATC
[U] sunitinib; oral
+∞
111.2
105
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
110.1
104
*
KAD00
NOMESCO Finland
Partial nephrectomy
578.8
108.6
106
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
154.4
107.1
112
8
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
106.9
101
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
104.8
99
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
104.8
99
*
180
Kela drug reimbursment
Interferon alfa
+∞
100.5
95
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.5
86.1
288
653
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
437.0
83.0
82
*
H02AB02
ATC
dexamethasone; systemic
25.9
81.6
115
49
JN4CD
NOMESCO Finland
Very extensive body CT
19.2
76.0
118
68
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
75.8
72
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
73.7
70
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
69.4
66
*
U75
ICPC
Malignant neoplasm of kidney
673.8
65.5
64
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
63.1
60
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
61.9
256
703
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
88.7
60.6
67
8
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.4
59.4
110
97
B01AB10
ATC
tinzaparin; parenteral
7.4
57.2
144
218
1502
Kela drug reimbursment
Cabozantinib
+∞
56.7
54
*
116
Kela drug reimbursment
Prostate cancer
+∞
56.7
54
*
3012
Kela drug reimbursment
Cabozantinib
+∞
55.6
53
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
22.8
54.3
79
37
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
53.5
51
*
C648
ICD-10 Finland
NA
+∞
52.5
50
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
141.3
51.2
54
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
50.0
585
3279
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
49.3
47
*
322
Kela drug reimbursment
Sunitinib
+∞
49.3
47
*
159
Kela drug reimbursment
Pazopanib
+∞
48.2
46
*
N02AA05
ATC
oxycodone; systemic
3.5
43.7
235
787
115
Kela drug reimbursment
Breast cancer
+∞
43.0
41
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
41.6
330
1443
158
Kela drug reimbursment
Everolimus
+∞
40.9
39
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
46.3
40.3
49
11
A04AA02
ATC
granisetron; systemic, transdermal
144.9
40.0
42
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
39.8
38
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
38.4
324
1458
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
37.7
36
*
L01XE26
ATC
[U] cabozantinib; oral
+∞
37.7
36
*
L01XE11
ATC
[U] pazopanib; oral
+∞
37.7
36
*
B01AB05
ATC
enoxaparin; parenteral
2.5
37.5
392
1984
Z51.5
ICD-10 Finland
Palliative care
7.4
37.2
91
131
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
367.9
36.2
36
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.2
35.8
100
173
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
27.7
35.2
48
18
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
34.5
165
499
L03AA04
ATC
NA
346.6
34.1
34
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
76.4
33.0
37
5
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
174.8
32.9
34
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
32.0
104
216
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.5
31.9
71
88
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
31.4
30
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
31.4
30
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
31.4
30
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.7
31.3
82
130
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
30.7
108
244
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.8
29.2
85
155
R31
ICD-10 Finland
Unspecified haematuria
3.0
28.9
188
707
L03AB05
ATC
interferon alfa-2b; parenteral
106.0
28.8
31
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
28.2
27
*
L01EX07
ATC
cabozantinib; oral
+∞
28.2
27
*
WZC30
NOMESCO Finland
Teaching
3.3
28.0
154
514
L02AE02
ATC
leuprorelin; implant, parenteral
54.7
27.3
32
6
L01BC06
ATC
capecitabine; oral
+∞
27.2
26
*
UKC02
NOMESCO Finland
Cystoscopy
2.5
27.0
252
1172
A04AA01
ATC
ondansetron; systemic, rectal
9.1
26.4
56
64
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
26.1
25
*
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
+∞
26.1
25
*
KA3LT
NOMESCO Finland
Njurlesion coagulation
266.0
25.8
26
*
L03AB04
ATC
interferon alfa-2a; parenteral
266.0
25.8
26
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
266.0
25.8
26
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
25.1
535
3542
WF002
NOMESCO Finland
Radical radiotherapy
59.3
25.1
29
5
198
Kela drug reimbursment
Sorafenib
+∞
25.1
24
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
25.1
24
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
24.7
155
567
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
11.1
24.7
47
44
L02BG04
ATC
letrozole; oral
49.4
24.4
29
6
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
24.0
23
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.7
23.9
70
129
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
88.6
23.7
26
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
244.6
23.7
24
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
42.3
23.7
29
7
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
23.0
22
*
168
Kela drug reimbursment
Axitinib
+∞
23.0
22
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
23.0
22
*
A11CC03
ATC
alfacalcidol; systemic
5.7
22.0
64
117
L01XE10
ATC
[U] everolimus; oral
+∞
21.9
21
*
L02BB03
ATC
bicalutamide; oral
223.8
21.7
22
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
21.2
140
528
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
20.9
20
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
213.5
20.6
21
*
SPAT1153
SPAT
Removal of sutures
1.9
19.1
362
2238
M04AA01
ATC
allopurinol; systemic
2.1
18.3
225
1172
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.5
18.3
43
59
XKD00
NOMESCO Finland
Uroflowmetry
2.1
18.1
230
1213
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
18.0
109
389
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
17.7
17
*
M05BA02
ATC
clodronic acid; systemic
+∞
17.7
17
*
Y77
ICPC
Malignant neoplasm prostate
+∞
17.7
17
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
17.7
17
*
L01XE05
ATC
[U] sorafenib; oral
+∞
17.7
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.7
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
17.7
17
*
L02BA01
ATC
tamoxifen; oral
+∞
17.7
17
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
17.7
17
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
17.7
17
*
L03AA13
ATC
pegfilgrastim; parenteral
182.5
17.6
18
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
182.5
17.6
18
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
17.5
94
309
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.3
17.2
41
58
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.2
16.9
24
11
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.0
16.7
68
178
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.8
16.7
42
64
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
16.7
16
*
L01XE17
ATC
[U] axitinib; oral
+∞
16.7
16
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
16.7
16
*
340
Kela drug reimbursment
Everolimus
+∞
16.7
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
91.3
16.6
18
*
N18.8
ICD-10 Finland
Other chronic renal failure
3.9
16.5
68
180
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
172.2
16.5
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
16.5
363
2338
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
16.3
128
534
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
30.5
16.1
21
7
TK800
NOMESCO Finland
Hemodialysis
5.2
15.9
49
97
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.4
15.7
32
35
WW500
NOMESCO Finland
Blood transfusion
4.9
15.7
51
107
A12AA04
ATC
calcium carbonate; oral
5.8
15.7
44
78
A79
ICPC
Malignancy NOS
+∞
15.7
15
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
15.7
15
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
15.7
15
*
343
Kela drug reimbursment
Pazopanib
+∞
15.7
15
*
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
22.4
15.6
22
10
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
162.0
15.5
16
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.1
15.5
32
36
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.7
15.5
53
118
R50.9
ICD-10 Finland
Fever, unspecified
2.2
15.2
164
803
HA1AA
NOMESCO Finland
X-ray mammography
5.2
15.1
47
94
N02AA01
ATC
morphine; systemic, rectal
8.2
15.1
33
41
M05BX04
ATC
denosumab; parenteral
3.6
14.8
67
193
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
14.6
14
*
L03AA02
ATC
filgrastim; parenteral
81.1
14.6
16
*
U14
ICPC
Kidney symptom/complaint
6.5
14.5
37
58
JN6AD
NOMESCO Finland
CT of torso and neck
36.5
14.5
18
5
ZXC96
NOMESCO Finland
Robot assisted procedure
15.6
14.4
23
15
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
14.4
169
856
J01MA02
ATC
ciprofloxacin; systemic
1.7
14.4
457
3254
C08CA01
ATC
amlodipine; oral
1.6
13.9
475
3439
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.4
13.8
32
44
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
14.9
13.6
22
15
205
Kela drug reimbursment
Chronic hypertension
1.6
13.6
441
3147
C50.99
ICD-10 Finland
Breast, unspecified
+∞
13.6
13
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
13.6
13
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
13.6
13
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
13.6
13
*
361
Kela drug reimbursment
Axitinib
+∞
13.6
13
*
B02AA02
ATC
tranexamic acid; systemic
2.3
13.5
129
594
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
141.5
13.5
14
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.6
13.4
34
53
Z31.5
ICD-10 Finland
Genetic counselling
5.8
13.4
37
65
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
13.3
59
168
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.2
13.3
50
123
N18.0
ICD-10 Finland
End-stage renal disease
6.2
12.9
34
56
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
12.5
12
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
12.5
12
*
L01EX01
ATC
sunitinib; oral
+∞
12.5
12
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
12.5
12
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
12.5
12
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
12.5
12
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
12.5
12
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
12.5
12
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
12.5
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
12.5
141
701
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
131.3
12.5
13
*
137
Kela drug reimbursment
Uraemia requiring dialysis
9.8
12.3
24
25
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.2
12.0
23
23
V03AE01
ATC
polystyrene sulfonate; oral
5.3
11.7
35
68
UJF32
NOMESCO Finland
Coloscopy
1.7
11.6
273
1768
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
11.5
11
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
11.5
11
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
11.5
11
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
11.5
11
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
11.5
11
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
11.5
11
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
121.1
11.4
12
*
7124
FHL
Nephrectomy (simple
121.1
11.4
12
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.9
11.3
20
17
S18
ICPC
Laceration/cut
1.6
11.3
417
3042
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.1
11.3
43
108
B03XA02
ATC
darbepoetin alfa; parenteral
5.0
11.2
35
72
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
11.1
70
257
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
6.2
11.1
29
48
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
11.0
89
375
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
7.5
11.0
25
34
J01MA12
ATC
levofloxacin; systemic
1.8
10.9
209
1264
ZX120
NOMESCO Finland
Intravenous
2.4
10.9
95
419
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
43.7
10.9
13
*
C03CA01
ATC
furosemide; systemic
1.5
10.8
458
3441
N02BE01
ATC
paracetamol; systemic, rectal
1.6
10.7
912
8027
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
60.5
10.6
12
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
60.5
10.6
12
*
RD211
NOMESCO Finland
NA
3.3
10.6
53
167
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
110.9
10.4
11
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
10.4
10
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
+∞
10.4
10
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
10.4
10
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
10.4
10
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
10.4
10
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
10.4
10
*
V03AE02
ATC
sevelamer; oral
16.2
10.4
16
10
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.0
10.1
27
46
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
10.0
63
232
Z90.5
ICD-10 Finland
Acquired absence of kidney
55.4
9.7
11
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.9
9.6
23
34
B05DA
ATC
Isotonic solutions
10.1
9.5
18
18
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
15.2
9.5
15
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.5
334
2382
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.1
9.5
50
165
JLC10
NOMESCO Finland
Distal pancreatectomy
100.8
9.4
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
9.4
9
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
9.4
9
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
9.4
48
155
JAH00
NOMESCO Finland
Laparotomy
3.8
9.4
38
102
C02AC05
ATC
moxonidine; oral
2.5
9.4
71
293
ZXA05
NOMESCO Finland
Left side
1.6
9.3
298
2078
ZXA00
NOMESCO Finland
Right side
1.6
9.2
310
2188
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
18.7
8.9
13
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
8.9
85
394
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
8.9
220
1431
A02BC02
ATC
pantoprazole; systemic
1.4
8.8
655
5458
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
8.8
33
83
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
50.3
8.7
10
*
127
Kela drug reimbursment
Transplant complication
7.7
8.7
19
25
A06AD11
ATC
lactulose; oral
1.7
8.6
204
1310
JMA10
NOMESCO Finland
Transabdominal total splenectomy
27.7
8.5
11
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
27.7
8.5
11
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
8.5
73
321
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
90.6
8.4
9
*
B03XA01
ATC
erythropoietin; parenteral
6.8
8.4
20
30
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
M907, C6488
ICD-10 Finland
NA
+∞
8.3
8
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.3
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.3
8
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
8.3
8
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.3
8
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
8.3
8
*
E83.50
ICD-10 Finland
Hypercalcemia
5.9
8.3
22
38
Z49.2
ICD-10 Finland
Other dialysis
9.5
8.3
16
17
WX402
NOMESCO Finland
General anaesthesia
1.9
8.1
117
643
TK820
NOMESCO Finland
Peritoneal dialysis
17.3
8.1
12
7
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
9.0
8.0
16
18
Z94.0
ICD-10 Finland
Kidney transplant status
9.0
8.0
16
18
JFB46
NOMESCO Finland
Resection of sigmoid colon
5.9
8.0
21
36
R33
ICD-10 Finland
Retention of urine
1.9
8.0
114
624
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.6
7.9
26
58
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
7.8
55
219
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.9
7.8
30
78
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
7.8
31
83
GDC00
NOMESCO Finland
Lobectomy of lung
45.2
7.7
9
*
J01EA01
ATC
trimethoprim; systemic
1.5
7.7
255
1782
1530
FHL
Urethrocystoscopy
3.3
7.6
36
111
BCA30
NOMESCO Finland
Unilateral adrenalectomy
18.5
7.6
11
6
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
7.6
48
177
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
25.2
7.6
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.5
296
2155
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
80.5
7.4
8
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
80.5
7.4
8
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
80.5
7.4
8
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
80.5
7.4
8
*
ZX112
NOMESCO Finland
Subcutaneous
6.5
7.4
18
28
XJH00
NOMESCO Finland
Transanal ultrasonography
2.1
7.4
81
400
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.4
163
1027
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.9
7.3
13
12
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.3
7
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
7.3
7
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
+∞
7.3
7
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
7.3
7
*
L02BG03
ATC
anastrozole; oral
+∞
7.3
7
*
B05DB
ATC
Hypertonic solutions
9.4
7.3
14
15
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
7.3
28
73
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.8
7.2
28
74
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.6
7.1
17
26
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.1
7.1
26
65
A06AH03
ATC
naloxegol; oral
8.8
7.1
14
16
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.1
7.0
13
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.0
97
525
G04CA02
ATC
tamsulosin; oral
1.5
7.0
325
2441
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
6.8
60
269
N07BC02
ATC
methadone; systemic
40.3
6.8
8
*
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
40.3
6.8
8
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
6.8
47
185
7321
FHL
TU biopsy, coagulation or laser
16.8
6.7
10
6
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
5.2
6.6
19
37
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
10.1
6.5
12
12
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
5.7
6.5
17
30
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.4
695
6032
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
70.2
6.4
7
*
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
70.2
6.4
7
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
14.4
6.4
10
7
306
Kela drug reimbursment
Erythropoietin and darbepoetin
14.4
6.4
10
7
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
14.4
6.4
10
7
C08CA13
ATC
lercanidipine; oral
1.6
6.4
161
1050
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
6.3
106
614
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
5.2
6.3
18
35
L02AE03
ATC
goserelin; implant
18.1
6.3
9
5
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
6.3
6
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.3
6
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
6.3
6
*
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
+∞
6.3
6
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
6.3
6
*
L01EX03
ATC
pazopanib; oral
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
6.3
6
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
6.3
6
*
U79
ICPC
Neoplasm urinary tract unspecified
+∞
6.3
6
*
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.8
6.2
19
40
GDA20
NOMESCO Finland
Excision of lesion of lung
26.8
6.2
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
6.2
41
159
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
3.7
6.2
25
69
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
6.2
47
195
S15
ICPC
Foreign body in skin
2.2
6.2
59
277
JFB30
NOMESCO Finland
Right hemicolectomy
5.8
6.1
16
28
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
12.6
6.1
10
8
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.6
6.1
10
8
196
Kela drug reimbursment
Paricalcitol and cinacalcet
12.6
6.1
10
8
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
12.6
6.1
10
8
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.6
6.1
12
14
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.6
6.1
12
14
321
Kela drug reimbursment
Paricalcitol and cinacalcet
8.6
6.1
12
14
L04AA06
ATC
mycophenolic acid; systemic
4.9
6.1
18
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
252
833
3.53
62.70
9.7
5.7
12.0
11.4
mmol/l
0.53
238
780
302
1253
2.85
50.06
8.6
4.3
1.1
1.0
mmol/l
4.30
277
1130
160
523
3.36
39.61
2.6
1.4
7.3
3.5
ug/l
0.76
130
397
538
3383
2.03
31.77
4.6
3.2
—
—
—
0
0
584
3823
1.98
30.35
4.8
3.7
—
—
—
0
0
185
769
2.65
29.43
5.5
3.5
133.2
91.8
ng/l
4.35
163
653
593
3967
1.93
28.30
7.3
3.7
34.0
34.9
g/l
2.96
558
3605
616
4285
1.85
25.04
10.4
4.9
1.2
1.2
mmol/l
1.35
580
3755
350
2027
2.00
24.85
3.2
2.5
2.9
4.7
e6/l
5.85
316
1765
259
1348
2.16
24.48
4.3
2.5
0.8
0.8
mmol/l
1.32
247
1226
205
973
2.32
24.24
4.1
2.6
255.8
242.0
u/l
0.46
197
900
627
4442
1.82
23.50
10.6
3.7
11.1
12.5
umol/l
1.02
601
4142
647
4712
1.76
21.34
12.6
5.3
1.2
1.2
mmol/l
0.26
556
3936
226
1189
2.10
20.47
6.0
6.2
12.8
11.3
kpa
4.24
218
1124
226
1189
2.10
20.47
6.0
6.2
5.1
5.1
kpa
0.31
219
1127
225
1188
2.09
20.17
6.0
6.2
0.2
1.3
mmol/l
3.72
175
909
635
4676
1.72
19.48
12.7
6.0
4.3
4.5
e9/l
1.29
569
3994
775
6071
1.71
18.56
6.2
4.7
497.3
3253.7
e6/l
1.42
18
115
320
1957
1.85
18.52
2.9
2.1
—
—
—
0
0
426
2843
1.75
18.36
4.3
3.2
122.9
92.9
e6/l
0.17
364
2209
394
2576
1.77
18.21
4.0
3.1
0.2
0.4
e6/l
5.20
335
1970
153
735
2.23
17.32
3.9
2.5
49.4
60.6
ml/min/173m2
6.79
104
314
436
2977
1.71
17.04
5.7
2.0
2.4
2.3
mmol/l
1.51
386
2417
843
6843
1.70
16.84
13.3
5.3
80.9
77.6
u/l
1.48
805
6263
45
113
4.09
16.30
1.3
1.3
22.2
8.1
u/l
2.87
34
92
234
1375
1.86
15.06
4.2
2.4
2.1
2.3
g/l
6.46
218
1253
62
204
3.14
15.03
2.8
2.5
1.9
1.7
mg/l
0.49
56
177
221
1281
1.88
14.83
4.4
2.5
19.9
22.5
%
2.46
188
1070
58
185
3.24
14.80
2.5
1.7
45202.6
79.0
u/ml
0.51
50
146
158
839
2.01
13.68
6.2
5.6
1.1
1.5
mmol/l
7.32
152
800
145
748
2.06
13.59
4.8
1.7
407.8
361.4
nmol/l
2.06
138
667
246
1518
1.77
13.35
4.2
2.4
10.3
12.6
umol/l
6.59
228
1371
131
665
2.08
12.81
1.8
1.6
—
—
—
0
0
360
2501
1.61
12.39
4.0
2.5
3612.0
7760.6
umol/l
0.94
308
2094
136
713
2.02
12.17
6.9
6.7
24.3
24.5
mmol/l
0.23
131
665
398
2853
1.58
11.92
3.8
2.2
64.7
59.6
u/l
0.56
374
2606
354
2496
1.58
11.28
6.4
4.2
0.0
0.0
estimate
0.50
112
730
244
1570
1.69
11.23
3.3
2.7
0.7
1.2
e6/l
2.89
157
910
679
5561
1.48
10.38
6.2
4.4
7.0
6.9
mmol/l
0.19
653
5214
37
114
3.31
10.04
4.4
5.8
85.0
468.7
iu/ml
—
5
13
454
3472
1.48
9.61
6.0
4.1
—
—
—
0
0
36
113
3.25
9.50
1.3
1.3
—
—
—
0
0
560
4478
1.45
9.33
7.2
5.1
0.0
0.0
estimate
0.00
120
762
565
4539
1.44
9.11
6.0
3.8
0.0
0.0
estimate
0.50
124
750
67
299
2.31
9.04
1.2
1.2
—
—
—
0
0
16
28
5.77
8.81
8.8
1.1
59.8
34.4
u/ml
—
5
5
556
4473
1.43
8.80
5.8
3.8
0.0
0.0
estimate
0.00
122
770
160
988
1.71
8.47
6.5
3.0
0.8
2.1
mmol/l
4.12
122
773
78
384
2.10
8.29
4.3
2.9
4.2
4.4
pmol/l
0.60
67
324
94
498
1.96
8.17
7.6
7.7
23.1
24.3
mmol/l
3.77
87
446
11
14
7.92
8.00
1.9
1.5
136.9
86.0
ng/l
0.52
11
14
158
990
1.68
7.91
6.1
3.0
5.7
5.8
kpa
0.62
153
952
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
338
2.13
7.83
2.3
2.7
0.4
0.4
u/ml
0.09
37
207
20
48
4.22
7.75
1.3
1.3
—
—
—
0
0
20
49
4.13
7.55
1.3
1.2
—
—
—
0
0
106
603
1.83
7.43
5.5
3.3
0.8
1.7
mmol/l
1.54
74
440
16
33
4.90
7.42
1.4
1.3
—
—
—
0
0
16
33
4.90
7.42
1.4
1.3
—
—
—
0
0
253
1799
1.51
7.38
5.4
2.2
2.5
2.4
mmol/l
7.87
225
1511
212
1455
1.55
7.29
3.7
2.9
2.1
2.1
e6/l
0.01
126
802
86
462
1.92
7.20
8.5
3.4
23.0
24.3
mmol/l
4.50
73
402
117
698
1.75
7.00
2.2
1.9
0.2
0.2
g/l
3.49
105
621
292
2159
1.46
6.98
6.6
4.2
1.0
1.0
kg/l
0.09
40
334
17
39
4.40
6.97
1.3
1.2
—
—
—
0
0
798
8891
0.72
6.90
6.0
5.0
6.1
6.1
mmol/l
0.09
721
7941
33
127
2.64
6.17
1.3
1.5
—
—
—
0
0
26
94
2.80
5.49
1.4
1.2
57.9
29.4
iu/l
2.45
18
82
209
1513
1.46
5.48
2.1
1.8
30.4
30.2
s
0.17
209
1459
822
9014
0.75
5.47
5.5
5.4
2.5
2.6
mmol/l
0.98
741
8154
186
1325
1.47
5.30
14.8
7.9
—
—
—
0
0
231
1716
1.42
5.27
1.8
1.8
—
—
—
0
0
29
114
2.58
5.23
1.4
1.5
2125.1
1677.5
e6/l
0.19
24
81
87
521
1.72
5.18
3.9
2.5
0.2
0.3
e6/l
0.31
87
508
9
10
9.05
4.78
10.2
5.6
4.8
6.3
mmol/l
—
9
10
38
177
2.18
4.75
1.3
1.5
—
—
—
0
0
40
191
2.13
4.71
1.3
1.4
—
—
—
0
0
801
8753
0.77
4.70
5.1
4.8
4.4
4.4
mmol/l
0.52
727
7958
83
506
1.69
4.65
5.7
6.9
24.0
24.8
mmol/l
1.36
83
501
124
836
1.54
4.60
2.8
1.6
65.7
66.8
g/l
0.70
115
739
70
412
1.74
4.46
1.3
1.2
126.0
130.0
iu/ml
0.03
19
167
393
3246
1.31
4.46
3.8
3.1
6.9
7.4
mmol/l
1.18
327
2716
436
3655
1.29
4.42
2.6
2.2
81.2
78.3
nmol/l
1.24
393
3132
56
311
1.84
4.33
2.7
2.9
—
—
—
0
0
43
219
2.00
4.30
1.4
1.4
238.6
284.9
ug/g
0.74
25
127
79
487
1.66
4.27
3.9
2.3
0.6
0.7
%
0.04
79
466
12
31
3.90
4.26
1.7
2.2
—
—
—
0
0
13
36
3.64
4.21
2.0
1.4
—
—
—
0
0
795
8650
0.78
4.18
5.0
4.7
1.4
1.4
mmol/l
4.61
719
7799
36
175
2.09
4.08
1.7
1.2
—
—
—
0
0
75
465
1.65
3.98
1.7
1.6
1.8
1.5
g/l
1.57
62
391
23
93
2.50
3.98
5.6
2.2
—
—
—
0
0
401
3366
1.28
3.93
4.7
3.9
25.9
8.2
mg/mmol
4.16
274
2161
21
84
2.53
3.72
1.8
2.2
—
477.2
—
0
10
24
103
2.36
3.68
1.4
1.5
184771.5
87571.2
e6/l
0.29
17
61
135
975
1.43
3.59
3.8
3.3
—
—
—
0
0
230
1812
1.33
3.59
1.6
1.6
1.3
1.4
mg/l
0.15
175
1414
164
1227
1.39
3.57
1.7
1.8
—
—
—
0
0
6
6
10.04
3.50
1.0
1.2
—
—
—
0
0
107
743
1.48
3.50
7.5
2.7
1.2
1.2
mmol/l
0.46
99
618
25
112
2.26
3.49
2.4
1.3
0.6
0.7
nmol/l
0.46
25
105
311
2567
1.28
3.43
3.7
2.5
34.7
34.7
u/l
0.00
295
2428
54
321
1.71
3.39
2.4
1.4
65.7
48.4
mg/l
0.96
46
255
54
321
1.71
3.39
2.4
1.4
50.4
38.0
mg/l
0.63
46
256
25
114
2.22
3.36
1.3
1.5
—
—
—
0
0
311
2573
1.28
3.36
2.4
2.2
3.6
3.0
mg/l
3.61
263
2151
123
887
1.43
3.31
3.1
2.3
9.8
9.0
umol/l
0.14
107
763
17
65
2.64
3.31
1.2
1.2
—
—
—
0
0
17
65
2.64
3.31
1.2
1.2
—
—
—
0
0
17
65
2.64
3.31
1.2
1.2
—
—
—
0
0
920
9746
0.79
3.22
39.6
21.5
130.0
134.7
g/l
14.39
903
9504
796
8565
0.81
3.22
7.7
6.5
41.8
41.1
mmol/mol
1.08
732
7814
417
3593
1.24
3.14
3.7
2.7
233.8
144.9
ug/l
5.02
373
3245
700
7620
0.82
3.11
25.1
16.3
37.8
39.0
%
1.79
412
4697
6
8
7.53
3.05
1.8
5.0
—
—
—
0
0
18
74
2.45
3.05
1.4
1.3
—
—
—
0
0
21
93
2.28
3.04
2.0
1.2
—
—
—
0
0
76
508
1.53
3.01
5.4
3.2
52.6
47.5
%
0.95
76
501
90
624
1.48
2.99
1.6
1.5
—
—
—
0
0
21
94
2.25
2.97
2.0
1.2
—
—
—
0
0
31
162
1.94
2.96
1.2
1.4
—
—
—
0
0
58
367
1.61
2.91
2.0
1.6
—
—
—
0
0
21
95
2.23
2.91
1.3
1.0
—
—
—
0
0
21
95
2.23
2.91
2.0
1.2
—
—
—
0
0
160
1234
1.34
2.89
1.7
1.8
—
—
—
0
0
22
102
2.18
2.88
1.3
1.2
112.8
108.2
u/ml
—
6
13
21
96
2.21
2.84
2.0
1.2
—
—
—
0
0
728
6687
1.21
2.80
5.1
4.1
18.4
13.6
mm/h
7.37
668
6086
21
97
2.18
2.78
2.0
1.2
—
—
—
0
0
21
97
2.18
2.78
2.0
1.2
—
—
—
0
0
780
8358
0.83
2.75
4.6
4.2
1.5
1.3
mmol/l
8.94
699
7467
101
729
1.42
2.74
2.6
2.0
165.5
31.7
u/l
0.51
88
595
22
105
2.11
2.69
1.3
1.3
—
—
—
0
0
26
135
1.95
2.56
1.3
1.3
—
—
—
0
0
75
519
1.47
2.56
2.5
2.2
11.8
14.8
nmol/l
1.40
64
450
143
1107
1.33
2.54
3.0
2.6
4.2
7.4
ug/l
5.13
124
949
16
69
2.34
2.49
1.5
1.3
—
—
—
0
0
42
256
1.66
2.48
1.2
1.1
—
—
—
0
0
22
109
2.04
2.47
1.2
1.3
—
—
—
0
0
6
12
5.02
2.40
1.2
1.0
4280.8
22.9
u/l
—
6
7
19
90
2.13
2.39
1.3
1.5
—
—
—
0
0
16
71
2.27
2.35
1.4
1.5
—
—
—
0
0
35
207
1.71
2.32
3.9
2.6
16.9
16.3
%
0.54
21
102
24
127
1.91
2.27
1.1
1.2
—
—
—
0
0
58
394
1.49
2.20
2.1
1.7
—
—
—
0
0
23
122
1.90
2.17
1.3
1.3
—
—
—
0
0
38
235
1.64
2.15
1.6
1.5
—
—
—
0
0
41
259
1.60
2.14
1.2
1.1
—
—
—
0
0
198
2371
0.80
2.11
1.7
1.6
1.6
1.3
mmol/l
2.32
167
1942
37
229
1.63
2.10
3.5
2.2
127.9
131.7
g/l
0.44
27
172
23
124
1.87
2.08
2.7
2.6
13.0
23.4
mg/l
—
6
24
28
162
1.74
2.03
1.6
1.8
2.9
4.3
iu/l
—
10
59
5
11
4.56
1.94
1.2
1.2
—
—
—
0
0
39
251
1.57
1.91
2.1
1.6
—
—
—
0
0
17
86
1.99
1.85
1.1
1.2
—
—
u/ml
—
0
0
151
1241
1.25
1.73
2.8
2.0
1.7
1.8
%
0.21
136
1072
12
55
2.19
1.67
2.2
1.5
1.2
2.9
u/field
—
5
45
903
9406
0.86
1.63
16.5
9.3
30.1
24.9
u/l
0.48
865
8930
776
8161
0.87
1.57
7.1
4.5
2.1
2.2
mu/l
0.18
711
7274
28
430
0.64
1.52
2.4
1.8
—
—
—
0
0
42
292
1.45
1.50
2.5
2.2
242.7
79.4
ug/min
1.22
28
171
51
370
1.39
1.45
1.9
1.5
3.4
3.2
g/l
0.62
37
282
11
52
2.13
1.44
1.3
1.4
—
—
—
0
0
46
331
1.40
1.38
1.9
1.5
1.5
0.5
g/l
0.74
41
276
10
47
2.14
1.34
3.6
3.6
—
—
—
0
0
9
43
2.10
1.30
1.3
1.4
—
—
—
0
0
5
18
2.78
1.28
1.6
1.2
30.8
30.5
%
—
5
13
18
107
1.69
1.26
1.7
1.3
—
—
—
0
0
46
338
1.37
1.25
1.2
1.2
—
—
—
0
0
918
9493
0.88
1.24
32.5
18.2
4.1
4.0
mmol/l
23.95
891
9176
6
25
2.41
1.24
1.7
1.9
—
—
—
0
0
8
36
2.23
1.24
1.3
1.2
—
—
—
0
0
442
4087
1.13
1.22
5.1
4.1
56.6
74.2
ng/l
0.45
368
3102
53
401
1.34
1.20
1.9
1.5
—
—
—
0
0
53
401
1.34
1.20
1.9
1.5
7.5
7.5
g/l
0.00
37
286
53
401
1.34
1.20
1.9
1.5
3.8
3.9
g/l
0.07
36
279
16
94
1.71
1.17
3.9
2.1
0.6
2.0
u/field
—
5
38
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
5
111
0.45
1.13
1.2
1.0
—
—
—
0
0
11
58
1.90
1.12
1.3
1.2
—
—
—
0
0
918
9472
0.89
1.11
32.4
18.1
139.1
139.7
mmol/l
7.88
893
9174
8
41
1.96
1.09
1.0
1.0
—
—
—
0
0
350
3212
1.12
1.08
2.2
2.2
147.2
261.7
u/l
2.30
328
2995
25
169
1.49
1.07
2.0
1.2
57.7
21.2
u/l
0.49
18
147
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
380
3510
1.12
1.05
3.6
3.1
2868.6
1839.1
ng/l
2.18
343
3034
671
7028
0.90
1.04
29.3
17.5
14.2
13.8
%
7.89
652
6811
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
22
316
0.69
0.94
1.1
1.0
—
—
—
0
0
31
226
1.38
0.93
4.4
3.3
24.3
28.5
mg/l
0.23
15
151
141
1604
0.86
0.90
1.2
1.2
0.7
2.0
u/ml
2.86
35
430
56
450
1.26
0.87
1.3
1.2
119.3
244.2
u/ml
2.54
45
407
8
44
1.82
0.86
1.4
1.4
—
—
—
0
0
8
45
1.78
0.84
1.5
2.4
—
—
—
0
0
17
114
1.50
0.79
1.0
1.1
—
—
—
0
0
78
659
1.20
0.78
1.8
1.7
—
—
—
0
0
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
47
378
1.25
0.75
2.0
1.5
10.2
10.7
g/l
0.34
38
310
20
141
1.43
0.75
4.0
3.0
58.9
59.8
%
0.09
20
141
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
25
184
1.37
0.74
1.4
1.6
—
—
—
0
0
410
4324
0.92
0.67
2.1
2.1
94.0
92.2
pmol/l
0.32
217
2229
5
28
1.79
0.66
1.0
1.1
909.2
1743.9
miu/ml
—
5
28
8
52
1.54
0.59
1.4
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.9
—
1.2
—
0
22
18
131
1.38
0.59
2.0
1.9
89.5
89.6
%
0.04
18
131
539
5183
1.07
0.57
3.4
3.0
55.6
51.0
u/l
0.69
484
4691
6
36
1.67
0.56
1.0
1.2
—
—
—
0
0
25
194
1.29
0.56
1.5
2.7
25.6
35.4
umol/l
3.58
17
164
53
449
1.19
0.56
4.8
4.3
1.6
1.7
%
0.74
48
427
65
749
0.86
0.54
1.7
1.7
1.5
1.6
%
0.68
55
619
30
241
1.25
0.52
1.4
1.4
—
—
—
0
0
30
241
1.25
0.52
1.4
1.4
—
—
—
0
0
19
143
1.33
0.52
2.9
2.2
106.2
105.3
mmol/l
0.44
19
143
19
143
1.33
0.52
2.9
2.2
4.3
4.1
mmol/l
1.04
19
143
807
8257
0.94
0.51
25.7
13.7
59.6
72.9
ml/min/173m2
49.49
724
6633
26
206
1.27
0.51
2.2
1.7
—
—
—
0
0
6
41
1.47
0.50
1.3
2.0
18.2
17.9
nmol/l
—
6
33
6
41
1.47
0.50
1.0
1.3
177.7
451.0
u/l
—
6
36
218
2328
0.92
0.49
3.2
2.7
0.9
0.8
ug/l
0.52
167
1627
7
109
0.64
0.48
1.0
1.1
—
86.2
—
0
21
7
48
1.46
0.47
2.9
1.1
—
—
—
0
0
7
48
1.46
0.47
2.9
1.1
—
—
—
0
0
5
33
1.52
0.41
1.4
1.0
—
—
—
0
0
436
4203
1.06
0.41
2.4
2.3
—
—
—
0
0
327
3418
0.94
0.41
4.8
3.9
23.1
24.2
%
0.59
184
1712
0
15
0.00
0.41
0.0
1.1
—
86.8
—
0
8
0
15
0.00
0.41
0.0
1.1
—
78.5
—
0
8
198
2101
0.93
0.39
4.7
4.2
258.8
445.7
ng/l
1.04
169
1802
16
124
1.29
0.38
1.4
1.4
—
—
—
0
0
100
1088
0.91
0.37
3.1
3.2
348.2
273.6
ng/l
0.62
93
1010
37
321
1.16
0.34
2.0
1.5
34.8
37.0
g/l
1.05
32
261
23
275
0.83
0.33
1.3
1.9
—
—
—
0
0
137
1290
1.07
0.29
1.2
1.2
13.6
14.4
u/ml
0.05
61
477
173
1642
1.06
0.29
30.4
30.4
1.6
1.5
inr
0.31
19
229
66
719
0.91
0.27
1.3
1.4
—
—
—
0
0
27
234
1.16
0.26
1.7
1.6
0.3
0.1
iu/ml
—
9
54
8
67
1.20
0.26
1.1
1.2
—
—
—
0
0
5
71
0.70
0.26
1.4
1.1
—
—
—
0
0
896
8856
1.04
0.25
25.2
14.8
32.2
26.1
mg/l
4.79
797
7028
38
340
1.12
0.24
1.6
1.9
33.9
39.6
u/l
0.97
33
278
242
2334
1.05
0.24
1.7
1.7
443.1
19630052.2
pmol/l
1.75
202
1890
11
135
0.81
0.22
1.4
1.1
—
—
—
0
0
14
167
0.84
0.21
1.1
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
221
2286
0.96
0.21
1.7
1.8
1369.4
1177.1
nmol/l
1.80
164
1716
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
9
113
0.79
0.20
2.7
4.0
—
—
—
0
0
19
167
1.14
0.17
1.4
1.4
—
—
—
0
0
27
298
0.90
0.16
3.0
3.2
0.8
0.8
nmol/l
0.41
19
227
262
2555
1.03
0.16
1.7
1.6
19.2
20.2
nmol/l
0.51
232
2132
91
869
1.05
0.15
1.3
1.3
—
—
—
0
0
7
90
0.78
0.14
1.1
1.1
—
—
—
0
0
30
278
1.08
0.12
1.2
1.3
—
—
—
0
0
119
1227
0.97
0.11
4.8
4.9
31.2
33.1
%
1.12
83
791
10
86
1.16
0.11
1.2
2.2
—
—
—
0
0
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
415
4198
0.98
0.09
5.3
3.9
5.7
2.2
ug/l
1.31
369
3713
18
196
0.92
0.09
1.5
1.5
—
—
—
0
0
6
55
1.09
0.09
1.8
1.7
18.2
14.2
umol/l
—
6
48
24
254
0.94
0.06
3.6
2.7
1.9
1.7
mmol/l
0.43
24
246
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
16
149
1.07
0.05
1.4
1.3
—
—
—
0
0
661
6631
0.99
0.03
6.4
3.7
15.4
15.1
pmol/l
2.97
612
5894
13
122
1.07
0.02
1.4
1.4
—
—
—
0
0
31
301
1.03
0.02
1.5
1.6
—
—
—
0
0
23
238
0.97
0.02
3.7
2.8
7.5
7.6
mmol/l
0.03
23
230
28
272
1.03
0.02
1.3
1.5
—
—
—
0
0
133
1338
0.99
0.01
1.3
1.3
19.4
37.9
iu/ml
3.92
39
423
16
158
1.01
0.00
1.1
1.4
—
—
—
0
0
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
15.0
—
0
9
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
5
59
0.85
0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
6
60
1.00
0.00
1.5
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
7
74
0.95
0.00
1.0
2.3
—
—
—
0
0
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RENAL_CELL_CARCINOMA_EXALLC – Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).